treatment of bmcs with high-dose interleukin-2 ( il-2 ) for 1 week followed by pma plus ionomycin resulted in a lymphocyte population in which 50 % and 3 % of cells expressed gm-csf and il-3 mrna , respectively .
C1321301
bmcs
C0007634
cells